Form 4 for CTNM Contineum Therapeutics, Inc.
Accepted 2026-07-10 17:20:40 ET · period of report 2026-07-08 · accession 0001628280-26-047909 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-10 17:20 | 2026-07-08+ | CTNM | Lorrain Daniel S. | CSO | M - OptEx | $1.01 | +1,040 | 135.2K | +0.8% | +$1,050 |
| DMT | 2026-07-10 17:20 | 2026-07-08+ | CTNM | Lorrain Daniel S. | CSO | S - Sale+OE | $16.00 | -1,040 | 135.2K | -0.8% | -$16.6K |
| DMT | 2026-07-10 17:20 | 2026-07-08+ | CTNM | Lorrain Daniel S. | CSO | M - OptEx | $0.00 | -1,040 | 33.3K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-07-08 | M | A | 1,015 | $1.01 | 136,217 | D | — | — | (F1) These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025. |
| 2 | Common | Class A Common Stock | 2026-07-08 | S | D | 1,015 | $16.00 | 135,202 | D | — | — | (F1) These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025. |
| 3 | Common | Class A Common Stock | 2026-07-09 | M | A | 25 | $1.01 | 135,227 | D | — | — | (F1) These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025. |
| 4 | Common | Class A Common Stock | 2026-07-09 | S | D | 25 | $16.00 | 135,202 | D | — | — | (F1) These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025. |
| 5 | Derivative | Stock Option (right to buy) | 2026-07-08 | M | D | 1,015 | $0.00 | 33,282 | D | $1.01 · — to 2030-02-24 | 1,015 Class A Common Stock | (F1) These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025. (F2) The stock options are fully vested and exercisable. |
| 6 | Derivative | Stock Option (right to buy) | 2026-07-09 | M | D | 25 | $0.00 | 33,257 | D | $1.01 · — to 2030-02-24 | 25 Class A Common Stock | (F1) These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025. (F2) The stock options are fully vested and exercisable. |